We are live on ! Find out more
MDSL

M.D. Sass LLC Portfolio holdings

AUM $1.32B
1-Year Est. Return 16.01%
This Fund
S&P 500
This Quarter Est. Return
-15.06%
1 Year Est. Return
+16.01%
3 Year Est. Return
+54.62%
5 Year Est. Return
+70.79%
10 Year Est. Return
+248.43%
AUM
$529M
AUM Growth
-$55.1M
Cap. Flow
+$30.3M
Cap. Flow %
5.73%
Top 10 Hldgs %
58.94%
Holding
37
New
6
Increased
14
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
MTZ icon
MasTec
MTZ
+$28.9M
2
FRC
First Republic Bank
FRC
+$28.3M
3
OWL icon
Blue Owl Capital
OWL
+$25.1M
4
ROK icon
Rockwell Automation
ROK
+$14.4M
5
FWONK icon
Liberty Media Series C
FWONK
+$9.32M

Top Sells

Rank Stock Value
1
QRVO icon
Qorvo
QRVO
+$31.5M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$25.3M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.5M
4
BHC icon
Bausch Health
BHC
+$18.2M
5
PWR icon
Quanta Services
PWR
+$9.71M

Sector Composition

Rank Sector Weight
1 Industrials 23.4%
2 Financials 19.16%
3 Technology 13.35%
4 Healthcare 12.11%
5 Communication Services 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPXS icon
26
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$332M
$886K 0.17%
+3,323
New +$754K
SJB icon
27
ProShares Short High Yield
SJB
$52.1M
$864K 0.16%
43,713
-23,602
-35% -$446K
TZA icon
28
Direxion Daily Small Cap Bear 3x ETF
TZA
$213M
$463K 0.09%
+993
New +$398K
OPCH icon
29
Option Care Health
OPCH
$3.4B
$418K 0.08%
15,026
– –
BHC icon
30
Bausch Health
BHC
$1.65B
– –
-796,776
Closed -$18.2M
JAZZ icon
31
Jazz Pharmaceuticals
JAZZ
$15.9B
– –
-162,666
Closed -$25.3M
META icon
32
Meta Platforms (Facebook)
META
$1.51T
– –
-10,365
Closed -$2.31M
QRVO icon
33
Qorvo
QRVO
$7.63B
– –
-253,904
Closed -$31.5M
SARK icon
34
Tradr 2X Long Innovation ETFShort Innovation Daily ETF
SARK
$45.1M
– –
-28,300
Closed -$3.93M
SCHW
35
Charles Schwab
SCHW
$177B
– –
-40,103
Closed -$3.38M
TMV icon
36
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$180M
– –
-33,420
Closed -$600K
TTT icon
37
ProShares UltraPro Short 20+ Year Treasury
TTT
$18.7M
– –
-23,120
Closed -$940K
1
2

Similar funds

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
GSEP
Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.32B AUM 24.91% 1-Year Est. Return
MCM
Mill Capital Management Concord, North Carolina $1.31B AUM 17.4% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return

M.D. Sass LLC's Q2 2022 Portfolio in Review

As of Q2 2022, M.D. Sass LLC held 37 positions worth $529M, down 9.4% from $584M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

M.D. Sass LLC deployed $30.3M of net new capital in Q2 2022, opening 6 new positions and adding to 14 existing holdings. Its largest new stake was MasTec: 370,773 shares worth $26.6M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $18.5M trimmed.

  • M.D. Sass LLC's largest Q2 2022 buy was MasTec: 370,773 shares worth $26.6M.
  • M.D. Sass LLC added most to Liberty Media Series C in Q2 2022, an estimated $9.32M increase.
  • M.D. Sass LLC's biggest Q2 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $18.5M.
  • M.D. Sass LLC fully exited Qorvo in Q2 2022, selling an estimated $31.5M.
  • M.D. Sass LLC's ten largest holdings make up 59% of its $529M portfolio in Q2 2022.
  • M.D. Sass LLC opened 6 new positions and closed 8 in Q2 2022.
  • M.D. Sass LLC's portfolio value fell 9.4% quarter-over-quarter to $529M.

Based on M.D. Sass LLC's 13F filing for Q2 2022, filed 15 Aug 2022.